Kingpins of opioid crisis tipped to settle lawsuits worth billions

Maker of OxyContin aims to declare bankruptcy once it has a settlement, insiders say, but some US states are resisting

WATCH: Adrian Gore presents Discovery’s annual results in a live webcast

Group CE Adrian Gore and his executive team present Discovery’s annual financial results live

NMT Capital welcomes divestment from ‘bullying’ Old Mutual

NMT Capital has accused Old Mutual of using it as a proxy in its battle with Peter Moyo, accusing the life insurer of insulting behaviour and pettiness

Aspen jumps most in 19 years as drugmaker trims debt

Market cheers company’s strong cash flow and better-than-expected gearing

Aspen’s share price jumps 12% on news of debt progress

Blue-chip drugmaker is selling off noncore assets to deal with its debt mountain

Ascendis appoints Mark Sardi as new CEO

The former Truworths CFO will take up the position on October 14 as the group disposes of assets and pursues a turnaround strategy

Adcock shares rise as prescription medicine boosts sales

Pharmaceutical company delivers robust results and improves profits in the year to end-June

Thebemed medical scheme placed under curatorship

Concerns over the scheme’s financial viability, its  appalling solvency ratio and, thus, its ability to cover claims, all informed the decision

WATCH: Discovery Health on NHI

Discovery Health CEO Jonathan Broomberg talks to Business Day TV about the new legislation

Discovery says NHI bill’s restriction of medical schemes ‘counterproductive’

Group says medical schemes will probably continue operating alongside National Health Insurance

NHI uncertainty wipes R14bn off healthcare firms’ values

Changing the healthcare system to one centred on a Fund that will purchase services on behalf of the entire population is sending shivers in the sector

Discovery closes near five-year low as plunge continues

Discovery’s share price closed at R105.72, down 8.44%, the second day of big losses for the share since the long-awaited NHI bill was unveiled by government on ...

Mediclinic to challenge Competition Tribunal ruling against it

Battle highlights the conundrum facing all three JSE-listed hospital groups, as they face regulatory constraints to domestic expansion and have struggled to ...

BP medical aid merger with Momentum turned down by regulator

Decision seen as unusual given that medical schemes industry is consolidating

Almost all RH Bophelo shareholders vote against pay policy

But RH Bophelo says it not have any employees, as staffing is under the care of RH Bophelo Management Company

Ascendis considers selling entire biosciences division

Ascendis has also been in talks about a possible sale of its Remedica business in Cyprus, which is seen as key to reducing Ascendis’s debt

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.